Baths salts, spice, and related designer drugs: the science behind the headlines. - Wikidata - awgldk - TriplyDB

Baths salts, spice, and related designer drugs: the science behind the headlines.

Baths salts, spice, and related designer drugs: the science behind the headlines.

http://www.wikidata.org/entity/Q34491601

about

Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal Synthetic cannabinoids 2015: An update for pediatricians in clinical practice Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.Identification and characterization of new designer drug 4-fluoro-PV9 and α-PHP in the seized materials Screening new psychoactive substances in urban wastewater using high resolution mass spectrometry.Abuse of New Psychoactive Substances: Threats and Solutions Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve Rats Self-Administration of JWH-018 A Synthetic Cannabinoid in Experimentally Naïve Rats Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters.Epidemiologic profile and triggering factors of voluntary poisoning in teenagers.Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.N-Alkylated Analogs of 4-Methylamphetamine (4-MA) Differentially Affect Monoamine Transporters and Abuse Liability.The Affective Properties of Synthetic Cathinones: Role of Reward and Aversion in Their Abuse.Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters.Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients.Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths.Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.The Growing Problem of New Psychoactive Substances (NPS).Staphylococcus aureus bacteraemia associated with injected new psychoactive substances.Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability Profiles in drug metabolism and toxicology: Richard Tecwyn Williams (1909-1979).A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan.Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ9 -tetrahydrocannabinol.Spectroscopic and crystallographic characterization of two cathinone derivatives: 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one (4-FPD) hydrochloride and 1-(4-methylphenyl)-2-(ethylamino)pentan-1-one (4-MEAP) hydrochloride.The newest cathinone derivatives as designer drugs: an analytical and toxicological review.Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.The Consumption of New Psychoactive Substances and Methamphetamine.A validated, sensitive HPLC-MS/MS method for quantification of cis-para-methyl-4-methylaminorex (cis-4,4'-DMAR) in rat and human plasma: application to pharmacokinetic studies in rats.

P2860

Q26748662-D91DABC0-DABA-46DF-A7E8-67F095238B31 Q26767016-E752E1CA-5149-4BB4-B264-BBB5E76B92E6 Q30148688-8E06CB52-3331-4E7F-AD9C-9FF58CC30A90 Q33566201-895FFB66-093E-4D08-AE89-35B8EED04676 Q34493739-655E5865-E4B5-4FF1-8B40-33B78D9FBF8A Q34510174-56EB8E20-DAC1-4ED6-99F1-F1E5CDF9848A Q35991838-1E460E70-F554-4449-9B39-EA5497011934 Q36449759-D78A299F-AF55-4954-BFCD-862C4AAC94D4 Q37058585-38D7AE1F-AA6C-4629-A1FB-023990B4A5F1 Q37073014-97937542-25FB-4088-BE0B-CB8B7FA7C183 Q37161370-557D52BC-E787-48B0-B9E8-E75FE4E7951F Q37626562-50EB8170-03BB-487F-BD72-9EA4FDDF1DF0 Q38622274-023B272E-41B8-4421-880F-27501D04B0AA Q38771797-D2F9D12D-A54E-4F6D-84FA-61493DDB4015 Q38840378-348B2BE3-3175-43EE-95B9-5D2208DA15B2 Q38983630-E3C32A77-C0F7-44DB-9CE3-D96F01FA7F96 Q39057330-D73F59E0-368D-4E28-BD32-A22E37021DD2 Q39479205-B89D6D62-07F7-4BA6-AC31-65D51CAE46FB Q40054798-1A78BFF8-E29A-4FC6-969F-CD4D8E83B405 Q40376788-722A1EB9-7526-4D5C-9464-881151697ABA Q40436637-803D4FF2-9B50-4023-B569-6719B46822B4 Q40603293-4E10C9DB-906D-448D-8BB6-1963ADBC9EAA Q40918288-299D066C-2C89-49C7-B5B0-E8A58299FDAC Q41640386-EF23BAC5-9054-4D72-A394-E9BE56B32CD5 Q46633307-755C94F5-C9F5-47C9-9014-2E026EA95888 Q47280432-6E207CCE-1E23-4200-BA98-6DE816F59089 Q48269342-2B71EADA-0CF3-423B-8564-F51326408714 Q49265185-D95EC71D-1F58-4A57-B3AE-1398D7F30E31 Q49723300-1B880EAA-365C-4063-A700-0DD7143B7681 Q50117427-CAE0CA00-7188-46E8-AFB0-B60C8EEDF45E Q50329792-55DC796E-6714-49DD-8450-EE8C5E80F17D Q51580421-BEE14DF5-0D6F-43B5-9BD3-457FA164DB0A

P2860

Baths salts, spice, and related designer drugs: the science behind the headlines.

http://www.wikidata.org/entity/Q34491601

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Baths salts, spice, and related designer drugs: the science behind the headlines.

@ast

Baths salts, spice, and related designer drugs: the science behind the headlines.

@en

Baths salts, spice, and related designer drugs: the science behind the headlines.

@nl

type

label

Baths salts, spice, and related designer drugs: the science behind the headlines.

@ast

Baths salts, spice, and related designer drugs: the science behind the headlines.

@en

Baths salts, spice, and related designer drugs: the science behind the headlines.

@nl

prefLabel

Baths salts, spice, and related designer drugs: the science behind the headlines.

@ast

Baths salts, spice, and related designer drugs: the science behind the headlines.

@en

Baths salts, spice, and related designer drugs: the science behind the headlines.

@nl

P1433

Q34491601-EF7AEDB4-F854-41E1-B469-1B86910C9AF7

P1476

Q34491601-DDC471B9-7318-4C72-A436-76EE80130E88

P2093

Q34491601-0CDA1EEC-0C99-472C-9272-80DEB94882BF

Q34491601-36B2B156-4AF4-42B0-A008-DE9D04A68C03

Q34491601-4B154968-9C8A-4441-8728-0681E29C52EB

P2860

Q34491601-028AA895-395C-41E3-87FE-6CD956F6ABF3

Q34491601-05A95BD7-BBD8-4888-B204-4766DA2DD405

Q34491601-05D4182D-7AF2-4DFA-AC28-D36600BB7BE5

Q34491601-066AFD19-01FD-43E8-8CC8-0437C5FB92C4

Q34491601-0A3FEB4B-BE03-4348-87EB-11CB79023EC3

Q34491601-0AC015FD-52EA-4324-B8FC-1F337D098531

Q34491601-0B5E91DA-0B41-47A9-9BF3-F9D362B8C176

Q34491601-0C748C76-0329-4FAC-BF9A-115EE76D28CE

Q34491601-0EAAA4B3-CF44-48BE-A4B9-BA6D29D8D809

Q34491601-0EDBBE0E-00C2-4A3C-8C5D-6AA75F19C165

P304

Q34491601-5A1A251B-1FAE-40AC-A5AB-505DC7617ABF

P31

Q34491601-8618A467-0581-42A5-B31E-E4F6700C2740

P356

Q34491601-AE5DD9FB-ACF0-4A5D-924C-6049AFDB65D2

P407

Q34491601-0E70975B-8EA2-4C47-A72C-70E7E783866F

P433

Q34491601-D5657E2A-3662-4723-8A12-E4E0EA4BE92C

P478

Q34491601-83AB5637-5783-4B74-A87D-BC6F2F8F14D6

P50

Q34491601-7726808E-5072-411F-B643-6CD22BE14E39

Q34491601-DA5FC462-001C-4462-900E-3D213475E17A

Q34491601-DF3FDCC9-3CCB-4AFF-A78F-CDD2EBE2FA00

P577

Q34491601-13D7362F-164C-440E-9C12-052BEF842A6C

P5875

Q34491601-3693A25D-9819-4075-9E08-AC70A9B0F2C8

P698

Q34491601-8A33B6DE-1458-4941-9202-734F6777DE20

P932

Q34491601-BAF5BF89-17F3-45BA-8402-9CBE76160F70

P356

JNEUROSCI.3223-14.2014

P1433

Journal of Neuroscience

P1476

Baths salts, spice, and related designer drugs: the science behind the headlines.

@en

P2093

Julie A Marusich

http://www.w3.org/2001/XMLSchema#string

Michael H Baumann

http://www.w3.org/2001/XMLSchema#string

William E Fantegrossi

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity

The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats

Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines

4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse

Beyond THC: The New Generation of Cannabinoid Designer Drugs

1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors

Presynaptic dopamine modulation by stimulant self-administration

Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids

P304

15150-15158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.3223-14.2014

http://www.w3.org/2001/XMLSchema#string

P407

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Lucas R Watterson

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268233426

http://www.w3.org/2001/XMLSchema#string

P698

25392483

http://www.w3.org/2001/XMLSchema#string

P932

4228124

http://www.w3.org/2001/XMLSchema#string